Lloyd’s protected cell company approved to promote investment in members

Patrick Bracher, Norton Rose Fulbright

In order to attract new forms of capital, Lloyd’s of London applied for and has had regulatory approval to set up a protected cell company known as London Bridge Risk.

The idea is to make it easier for investment in the Lloyd’s market with a more transparent and efficient capital management process. It provides access for both UK and international investors including insurance-linked securities investors. Investors will be able to back, and provide capital to, members at Lloyd’s under a process which is said to be quicker, more tax transparent and streamlined.

First published by: Financial Institutions Legal Snapshot